Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets - Wikidata - awgldk - TriplyDB

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

http://www.wikidata.org/entity/Q28344493

about

Role of AMP-activated protein kinase in mechanism of metformin action Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial Mechanisms of nutritional and hormonal regulation of lipogenesis Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease Endocrine causes of nonalcoholic fatty liver disease Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid.Linoleic acid suppresses cholesterol efflux and ATP-binding cassette transporters in murine bone marrow-derived macrophages Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance.Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes Lipotoxicity and decreased islet graft survival Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesity Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.Experimental models of non-alcoholic fatty liver disease in rats.Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3β independent of JNK activation.Insulin-regulated Srebp-1c and Pck1 mRNA expression in primary hepatocytes from zucker fatty but not lean rats is affected by feeding conditions Nutrient sensing, leptin and insulin action.The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress.New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes.Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Catechins and Caffeine Inhibit Fat Accumulation in Mice through the Improvement of Hepatic Lipid Metabolism NAD(P)H cytochrome b5 oxidoreductase deficiency in Leishmania major results in impaired linoleate synthesis followed by increased oxidative stress and cell death The evolving role of leptin and adiponectin in chronic liver diseases.Nutrigenomics, beta-cell function and type 2 diabetes Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism.

P2860

Q22241898-273B016B-C225-4D99-96E0-03B026EFFA89 Q22242637-4D3904A8-CCB6-4D1E-A158-8808842461D8 Q24522517-FFFA87D4-9B9C-4B5F-9E11-49F0DA67842A Q24803245-4243EC6D-011A-43CD-95E0-D8870B833025 Q26738646-4681452B-F27F-4FA8-8EBF-A9C0F8D4BD7A Q26780254-CCC35316-DD39-4FE2-B0FC-89A0E9D727B0 Q28294805-90126493-659F-472A-BAA3-54C5237A8C38 Q28504868-422D0005-4867-4C81-8E6E-4C2C9E58814E Q28569638-F44F9CE2-57D4-47D0-881B-86C9D3A157EB Q28581281-25542D33-86C2-4540-A684-EF2EBD30CC79 Q28582308-0A3F9DEF-7F3F-46C5-A38F-031B5C9ECCF1 Q33184238-B4251A82-9CA0-4DFD-82C2-3C77F37759B6 Q33565875-4D4AED69-CB23-4BF8-83FC-F6905E24F3BD Q33580624-72968B1E-DAE4-4125-8861-85CBFB3A9259 Q33587148-5F756EFC-79CF-402E-8546-B3D000CC8E64 Q33608251-569BF7DF-912A-4DD2-957E-2F16585C97DF Q33683805-774AAFA2-ADA0-482F-AED7-0380F2E8161D Q33716026-849B3ABB-962E-4A7A-8362-29C0320F6210 Q33727061-57033CCD-A488-494E-A433-941AF5E329BA Q33782820-B1DD89E4-0371-4416-9B13-79E47A4663AD Q33789340-4248285D-B61F-418B-B8CC-E5D19BC7F23C Q33867088-2FE9834D-E906-496C-A873-983562C01287 Q33886936-45CEFFB0-9ABB-4741-AED4-BEDEB7D04043 Q33889357-EEA62CAC-4924-4C1D-A2AD-9351900BFEB0 Q33952316-D4FF6CBF-18A6-47D4-B8C0-A49CA6AEF89D Q34318314-FD72D5DE-0B47-4B39-A3A3-49FD57FAB820 Q34412580-13856380-6949-47EA-B15F-25859AA0943D Q34526596-196694CF-F761-4F5A-B3B3-88726906B80B Q34541913-893EF235-51C9-4E61-814B-912EC12993CB Q34682304-8666DC73-6CB8-4510-86C5-DC6E5174DD66 Q34779049-E7F1094A-DB32-41B0-B212-A111E48478E0 Q35022545-0FF6AEAB-941C-4E8D-B80B-77A7989F2E22 Q35175722-E28B7E94-26CF-43C6-B036-121071026375 Q35538766-721DDD05-B6BB-4DC1-AE51-A0D6764B7910 Q35876759-12EB3469-53E5-4F8C-88AA-E426D4E9D682 Q36151994-E65248DD-6BB7-4AFB-9E2F-02A468F64103 Q36318852-DE20DDEC-2C8A-4FB6-9628-D908E3A48A90 Q36585280-24347249-1B71-4472-A635-862F9AF0357F Q36775874-8530DA75-E739-4C84-A1FC-DEBC3D5332EF Q36807697-38961A37-2D22-4FAA-9C2F-27C1F2BE40AB

P2860

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

http://www.wikidata.org/entity/Q28344493

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@ast

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@en

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@nl

type

label

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@ast

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@en

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@nl

prefLabel

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@ast

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@en

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@nl

P1433

Q28344493-7F44437B-696E-41B3-ACB9-72A0E5666A75

P1476

Q28344493-4663BF8D-25CD-4147-A48E-2D92BB39374E

P2093

Q28344493-3164C400-28C3-4BBC-8542-37B2817694A9

Q28344493-43BC4CA4-6A07-44C1-BB90-8FA621685220

Q28344493-47E77EE1-B2D3-4353-97C3-903142527CB5

Q28344493-50CEECC9-83F9-48D2-B1A7-DFD85989BA8A

Q28344493-A61B0C3A-E204-44BC-A9F8-D134F3961C82

Q28344493-BC8732FD-AFE6-4ABF-A1D9-D9DB06ED9E01

Q28344493-FD1024CC-C35A-4ECD-8EE7-B3816BAE06A5

P2860

Q28344493-09E1D0DF-7F44-4FF8-B69A-AFE554B5F959

Q28344493-0B5737B5-984F-421B-A4A0-9C4F1A28B65D

Q28344493-0F4EBD84-23AC-4EF6-BA61-773D993B312A

Q28344493-1A39F8AF-35D6-4EBF-A3FA-B72CEF0319A2

Q28344493-2154D6A9-4E91-4D45-922B-ED55EA2E3607

Q28344493-28D65ED7-8EF6-4D3C-B32F-330A3FB65052

Q28344493-32805AFD-B506-4781-839D-F4D4EF094E97

Q28344493-343D0C8B-875A-42C8-8B08-5F5D5F973A2C

Q28344493-3F9B3DC8-3D9C-4FBE-B045-C666C35884CF

Q28344493-44D2119A-7161-4615-BA81-2DD74B28496F

P304

Q28344493-3404F07B-E38A-4DB0-8565-3E5AFF66159C

P31

Q28344493-75645208-A493-4B4B-8F78-9DFBC70022B9

P3181

Q28344493-6C070F42-192F-43BA-A930-CB448D63B513

P356

Q28344493-C49AC197-35E1-4E5C-BBF2-E974FDE3484B

P407

Q28344493-AEA4E081-99EA-4E38-B5FD-B83F9FCAB4EC

P433

Q28344493-F84EEBCC-785D-47CE-84FC-09CF15E8014A

P478

Q28344493-0DDABFC4-F9BB-462F-B764-8AA84A79D819

P577

Q28344493-2D5C08D4-9EFC-49D7-96B2-E3D6F7186A98

P5875

Q28344493-AED3D25B-CAAA-4B8F-A750-09F77A3722B0

P698

Q28344493-EBEAF956-B112-4248-9D10-F16C35EEED5F

P932

Q28344493-B447238D-CBCA-4C46-A270-42DA5862FA3A

P3181

P356

PNAS.97.15.8536

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Leptin, troglitazone, and the ...... in liver and pancreatic islets

@en

P2093

I Shimomura

http://www.w3.org/2001/XMLSchema#string

M Higa

http://www.w3.org/2001/XMLSchema#string

R H Unger

http://www.w3.org/2001/XMLSchema#string

T Kakuma

http://www.w3.org/2001/XMLSchema#string

W Pan

http://www.w3.org/2001/XMLSchema#string

Y Lee

http://www.w3.org/2001/XMLSchema#string

Z w Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

A simple method for the isolation and purification of total lipides from animal tissues

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen

ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose

Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

Leptin-specific patterns of gene expression in white adipose tissue.

Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

P304

8536-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3763158

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.97.15.8536

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235615059

http://www.w3.org/2001/XMLSchema#string

P698

10900012

http://www.w3.org/2001/XMLSchema#string

P932

26983

http://www.w3.org/2001/XMLSchema#string